Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2009-03-04
2010-10-19
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C424S009100, C424S184100, C424S185100, C424S190100, C424S234100, C424S246100, C530S300000, C530S350000, C536S023100, C536S023700
Reexamination Certificate
active
07815896
ABSTRACT:
Disclosed is a newly identified and characterized type III secretion system inAeromonas salmonicida. The invention also encompasses the use of components of the novel secretion system in immunoprotection againstA. salmonicidainfection, as well as other diagnostic and therapeutic uses thereof.
REFERENCES:
Karlyshev, et al., Gene, 158:77-82 (1995).
Noonan, et al., Gene, 175:127-131 (1996).
Yahr, et al., Journal of Bacteriology, 179:22:7165-7168 (1997).
Yahr, et al., Database Accession No. AF010150, XP002216597.
Ellis, A.E., “Immunization with bacterial antigens: furunculosis”, Dev. Biol. Stand., vol. 90, pp. 107-116, 1997.
Thornton, J.C. et al., “Novel antigens expressed byAeromonas salmonicidagrown in vivo”, Infect. Immun., vol. 61, pp. 4582-4589, 1993.
Burian Jan
Frey Joachim
Kuzyk Michael A.
Stuber Katja
Thornton Julian C.
Swartz Rodney P.
Universitat Bern
LandOfFree
Type III secretion pathway in Aeromonas salmonicida and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type III secretion pathway in Aeromonas salmonicida and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type III secretion pathway in Aeromonas salmonicida and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4221506